Viatris Inc (VTRS) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Over the past 4 years, Viatris Inc has achieved a revenue compound annual growth rate (CAGR) of 5.4%, while earnings have grown at -1.4% CAGR.
Historical revenue and profitability trends for Viatris Inc
The chart above illustrates Viatris Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.
Annual percentage change in revenue and earnings
Growth rates provide insight into the momentum of Viatris Inc's business.
How efficiently Viatris Inc converts revenue into profit
Profit margins reveal how much of each dollar of revenue Viatris Inc retains at different stages:
Analyst estimates and forward-looking indicators
Wall Street analysts project Viatris Inc to continue growing earnings in the coming year. The consensus analyst rating is 3.4444 based on 9 analysts.
Based on our comprehensive analysis, Viatris Inc (VTRS) demonstrates declining growth characteristics.
This growth analysis provides a comprehensive view of Viatris Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.
See how Viatris Inc stacks up against similar companies
Explore growth analysis for top stocks
Related: VTRS Valuation, VTRS Dividend, VTRS Financial Health
Compare: VTRS vs AAPL, VTRS vs MSFT, VTRS vs GOOGL